GI
BLFS

GAMMA Investing’s BioLife Solutions BLFS Stock Holding History

GAMMA Investing’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$375K Buy
9,647
+651
+7% +$22K 0.01% 872
2026
Q2 		$254K Buy
8,996
+2,410
+37% +$56.3K 0.01% 1090
2026
Q1 		$126K Buy
6,586
+3,207
+95% +$70.9K 0.01% 1494
2025
Q4 		$81.7K Buy
3,379
+130
+4% +$3.4K ﹤0.01% 1721
2025
Q3 		$82.9K Sell
3,249
-268
-8% -$6.36K ﹤0.01% 1639
2025
Q2 		$75.8K Sell
3,517
-706
-17% -$15.9K ﹤0.01% 1634
2025
Q1 		$96.5K Buy
4,223
+663
+19% +$17.5K 0.01% 1286
2024
Q4 		$92.4K Buy
3,560
+265
+8% +$6.59K 0.01% 1173
2024
Q3 		$82.5K Buy
3,295
+748
+29% +$17.7K 0.01% 1130
2024
Q2 		$54.6K Sell
2,547
-112
-4% -$2.17K 0.01% 1130
2024
Q1 		$49.3K Buy
2,659
+265
+11% +$4.63K 0.01% 1056
2023
Q4 		$40.7K Buy
+2,394
New +$30.5K 0.01% 1021

Other funds holding BLFS

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

GAMMA Investing's BLFS Position: Q3 2026 in Review

GAMMA Investing increased its BioLife Solutions (BLFS) stake by 7.2% in Q3 2026, buying an estimated $22K and bringing the position to 9,647 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #872.

GAMMA Investing first reported a position in BLFS in Q4 2023 and has held it in 12 quarters since. 5 funds tracked by Wall St. Rank hold BLFS as of Q3 2026.

  • GAMMA Investing held 9,647 shares of BioLife Solutions worth $375K as of Q3 2026.
  • GAMMA Investing bought 651 BioLife Solutions shares in Q3 2026, an estimated $22K.
  • BioLife Solutions made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #872 holding.
  • GAMMA Investing first reported a position in BioLife Solutions in Q4 2023 and has held it in 12 quarters since.
  • 5 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.